
Nanosuspension for the delivery of a poorly soluble anti-cancer kinase inhibitor
Keywords: AUC, area under the curve; CL, caprolactone; DMEM, Dubelcco’s modified Eagle’s medium; EDTA, ethylenediaminetetraacetic acid; EGFR, epidermal growth factor receptor; EMA, European Medicine Agency; EPR, enhanced permeability and retention effect; FDA, Food